Login / Signup

Targeting the SARS-CoV-2 3CLpro and NO/cGMP/PDE5 pathway in COVID-19: a commentary on PDE5 inhibitors.

Milad Shirvaliloo
Published in: Future cardiology (2021)
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • nitric oxide
  • coronavirus disease
  • cancer therapy